Summary
The metabolism and pharmacokinetics of mebendazole was studied in rats using [2′-3H]-mebendazole (biologically stable; specific activity 383.9 (mCi/mMol) and [2-l4C]-mebendazole (specific activity 2.57 mCi/mMol). Analyses were performed by high pressure liquid chromatography and liquid scintillation spectrometry. About 85% of an intravenous dose was eliminated with the bile and the remainder with the urine. The majority of the dose was recovered as conjugated metabolites. The major metabolite (methyl-5(6)-(α-hyciroxybenzyl)-2-benzimidazole carbamate) accounted for about 77 % of the total recovered and 99 % of it was conjugated. Anaerobic metabolism studies conductedin vitro with intestinal micro-organisms obtained from rats indicated that metabolism of mebendazole did not occur in the gut, but that the intestinal microflora was able to hydrolyse conjugated metabolites which were eliminated with the bile. Mebendazole was found to have a biphasic elimination profile after intravenous administration. Its terminal plasma elimination half-life was 3.2 hours and its re-distribution half-life was 0.4 hour. After oral administration, as a solution in aqueous dimethyl sulphoxide, a bioavailability of 53 % was obtained.
Similar content being viewed by others
References
Brugmans, J.P., Thienpont, D.C., Van Wijngaarden, I., Vanparijs, O.F., Schuermans, V.L. and Lauwers, H.L. (1971). Mebendazole in Enterobiasis. Radiochemical and Pilot Study in 1,278 Subjects.J. Am. Med. Assoc., 217: 313–316.
Meuldermans, W.E.G., Hurkmans, R.M.A., Lauwers, W.F.J, and Heykants, J.J.P. (1976). Thein vitro Metabolism of Mebendazole by Pig, Rat and Dog Liver Fractions.Eur. J. Drug Metab. Pharmacokinetics 1: 35–40.
Allan, R.J. and Watson, T.R. (1982). Identification of Biliary Metabolites of Mebendazole in the Rat.Eur. J. Drug Metab. Pharmacokinetics, 6: 131–136
Allan, R.J., Goodman, H.T. and Watson, T.R. (1980). Two High Performance Liquid Chromatographic Determinations for Mebendazole and its Metabolites in Human Plasma using a Rapid Sep Pak C18 Extraction.J. Chromatog., 183: 311–319.
Upton, R.A. (1975). Simple and Reliable Method for Serial Sampling of Blood from Rats.J. Pharm. Sci., 64: 112–114.
Allan, R.J. and Roxon, J.J. (1977). The Effect of Dioctyl Sodium Sulphosuccinate on Tartrazine Azo Reduction by Intestinal Bacteria.Xenobiotica 7: 181–186.
Hirom, P.C., Millburn, P. and Smith, R.L. (1976). Bile and Urine as Complementary Pathways for the Excretion of Foreigh Organic Compounds.Xenobiotica 6: 55–64.
Wolf, D.E., Vanden Heuvel, W.J.A., Tuler, T.R., Walker, R.W., Koniuszy, F.R., Gruber, V., Arison, B.H., Rosegay, A., Jacob, T.A. and Wolf, F.J. (1980). Identification of a Gluthathione Conjugate of Cambendazole Formed in the Presence of Liver Microsomes.Drug Metab. Disposition 8: 131–138.
Smith, R.L. (1973). The Excretory Function of Bile. Chapman and Hall Ltd., London.
Scheline, R.R. (1973). Metabolism of Foreigh Compounds by Gastrointestinal Microorganisms.Pharmacol. Rev., 25: 451–532.
Millburn, P., Smith, R.L. and Williams, R.T. (1967). Biliary Excretion of Foreign Compounds. Biphenyl, Stilboestrol and Phenolphthalein in the Rat: Molecular Weight, Polarity and Metabolism as Factors in Biliary Excretion.Biochem. J., 105: 1275–1281.
Gibaldi, M. andPerrier, D. (1975). Pharmacokinetics.In Drugs and the Pharmaceutical Sciences, Volume 1,Editor J. Swarbrick. Marcel Dakker, Inc., New York.
Niazi, S. (1977). Application of a Programmable Calculator in Data Fitting According to One and Two Compartment Open Models in Clinical Pharmacokinetics.Computer Programs Biomed., 7: 41–44.
Michiels, M., Heykants, J., Van den Bossche, H. and Verhoeven, H. (1980). A Comparative Study on the Systemic Absorption of Oral and Subcutaneous Mebendazole, Flubendazole and R 34803 in Two Different Rodents. Janssen Research Products Information Service. Preclinical Research Report Nos R 17635/13, R 17889/12 and R 34803/5.
Miinst, G.J., Karlaganis, G. and Bircher, J. (1980). Plasma Concentrations of Mebendazole During Treatment of Echinococcosis: Preliminary Results.Eur. J. Clin. Pharmacol., 17: 375–378.
Witassek, F., Burkhardt, B., Eckert, J. and Bircher, J. (1981). Chemotherapy of Alveolar Echinococcosis — Comparison of Mebendazole Plasma Concentrations in Animals and Man.Eur. J. Clin. Pharmacol, 20: 427–433.
Braithwaite, P.A., Roberts, M.S., Allan, R.J. and Watson, T.R. (1982). Clinical Pharmacokinetics of High Dose Mebendazole in Patients Treated for Cystic Hydatid Disease.Eur. J. Clin. Pharmacol, 22: 161–169.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allan, R.J., Watson, T.R. The metabolic and pharmacokinetic disposition of mebendazole in the rat. European Journal of Drug Metabolism and Pharmacokinetics 8, 373–381 (1983). https://doi.org/10.1007/BF03188769
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03188769